| Literature DB >> 35982881 |
Sindhusuta Das1, Nonika Rajkumari1, Anitha Gunalan1, Dhanalakshmi Rajavelu1, Jeby Jose Olickal2.
Abstract
Objectives Amoebiasis is caused by the most common intestinal protozoan parasite Entamoeba histolytica . This parasite causes amoebic colitis, which is manifested by diarrhea, followed by dysentery. The laboratory diagnosis of intestinal amoebiasis in most cases is by microscopic examination of stool samples. Other nonroutine methods include coproantigen enzyme-linked immunosorbent assay (ELISA) from stool samples, serum ELISA for antibodies, stool culture, isoenzyme analysis, and polymerase chain reaction (PCR). The present study aimed to comparatively analyze the different diagnostic modalities used for the detection of E. histolytica from the stool sample of patients with intestinal amoebiasis. Materials and Methods This study was undertaken with 631 patients, during a period of 3 years, from January 2017 to December 2019. Stool specimen obtained from each patient was subjected to direct microscopic wet mount examination, coproantigen ELISA, and nested multiplex PCR, respectively. Results Out of all the patients tested, 5.2% were positive for E. histolytica. Among the positive cases, stool microscopy was positive in 3.17%, coproantigen ELISA was positive in 29 (4.6%) cases, and PCR was positive in 30 (4.75%) cases. Statistical Analysis The prevalence of E. histolytica infection was summarized as percentages. The three diagnostic tests done were statistically analyzed, taking microscopy as the gold standard. The agreement between techniques (microscopy, coproantigen ELISA, and PCR) was analyzed with kappa statistics. Sensitivity, specificity, positive predictive value, negative predictive value, and diagnostic accuracy were summarized as percentage with 95% confidence interval. Conclusion In all suspected amoebiasis cases, a combination of stool microscopy, coproantigen testing with molecular detection of the parasite offers the best approach to diagnosis of this parasitic infection. The Indian Association of Laboratory Physicians. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial-License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).Entities:
Keywords: Entamoeba histolytica; amoebiasis; amoebic colitis; amoebic dysentery; coproantigen testing
Year: 2021 PMID: 35982881 PMCID: PMC9381307 DOI: 10.1055/s-0041-1732488
Source DB: PubMed Journal: J Lab Physicians ISSN: 0974-2727
Fig. 1( A,B,C ) The serial stepwise locomotion images of a motile Entamoeba histolytica trophozoite found in a positive stool sample of a case. ( D ) The quadrinucleate cyst of E. histolytica found in the stool sample of a positive case.
Fig. 2Amplified products of PCR were analyzed by agarose gel electrophoresis. The size of the amplification product is indicated on the right (in base pairs). Samples 1 and 2 are negative for Entamoeba histolytica and the PCR products showing the bright band at 439 bp (samples 29 and 30) are positive for E. histolytica , along with the positive and negative controls used for the nested multiplex PCR. NTC, no template control; NEC, negative extraction control; PC, positive control; PCR, polymerase chain reaction.
Result showing the comparative performance of different diagnostic methods ( n = 631)
| Result | Microscopy | % | Serology by coproantigen ELISA | % | PCR | % |
|---|---|---|---|---|---|---|
|
| 20 | 3.17 | 29 | 4.60 | 30 | 4.75 |
|
| 611 | 96.83 | 602 | 95.40 | 601 | 95.25 |
Abbreviations: ELISA, enzyme-linked immunosorbent assay; PCR, polymerase chain reaction.
Age and sex distribution of the positive cases ( n = 33)
| Age | Male | % | Female | % |
|---|---|---|---|---|
| 0–14 | 1 | 3.03 | 0 | 0 |
| 15–25 | 3 | 9.09 | 1 | 3.03 |
| 26–35 | 5 | 15.2 | 4 | 12.2 |
| 36–45 | 8 | 24.2 | 2 | 6.06 |
| 46–55 | 1 | 3.03 | 3 | 9.09 |
| > 55 | 5 | 15.2 | 0 | 0 |
| Total | 23 | 69.7 | 10 | 30.3 |
Matrix showing the result of testing method of each positive cases with % positivity among the 3 stool samples of each case ( n = 33)
| Sl. no. | Microscopy | ELISA | PCR |
|---|---|---|---|
| 1 | + (100%) | + (100%) | + (100%) |
| 2 | + (100%) | + (100%) | + (100%) |
| 3 | + (100%) | + (100%) | + (100%) |
| 4 | + (66.6%) | – | + (66.6%) |
| 5 | + (66.6%) | + (66.6%) | + (66.6%) |
| 6 | – | + (66.6%) | + (66.6%) |
| 7 | – | + (66.6%) | – |
| 8 | – | – | + (66.6%) |
| 9 | + (100%) | + (100%) | + (100%) |
| 10 | + (100%) | + (100%) | + (100%) |
| 11 | + (100%) | + (100%) | + (100%) |
| 12 | + (66.6%) | – | + (66.6%) |
| 13 | + (100%) | + (100%) | + (100%) |
| 14 | – | + (66.6%) | – |
| 15 | – | + (66.6%) | + (66.6%) |
| 16 | – | – | + (66.6%) |
| 17 | + (100%) | + (100%) | + (100%) |
| 18 | – | + (66.6%) | – |
| 19 | + (100%) | + (100%) | + (100%) |
| 20 | + (100%) | + (100%) | + (100%) |
| 21 | + (100%) | + (100%) | + (100%) |
| 22 | + (100%) | + (100%) | + (100%) |
| 23 | + (100%) | + (100%) | + (100%) |
| 24 | + (100%) | + (100%) | + (100%) |
| 25 | + (100%) | + (100%) | + (100%) |
| 26 | – | + (66.6%) | + (100%) |
| 27 | – | + (66.6%) | + (100%) |
| 28 | – | + (100%) | + (100%) |
| 29 | + (100%) | + (100%) | + (100%) |
| 30 | + (100%) | + (100%) | + (100%) |
| 31 | – | + (66.6%) | + (66.6%) |
| 32 | – | + (100%) | + (100%) |
| 33 | – | + (100%) | + (100%) |
Abbreviations: ELISA, enzyme-linked immunosorbent assay; PCR, polymerase chain reaction.
Agreement between gold standard (microscopy) and ELISA
| ELISA | Microscopy | Kappa | |
|---|---|---|---|
| Positive | Negative | ||
| Positive | 18 | 11 | 0.79 (0.72–0.87) |
| Negative | 2 | 600 | |
| Total | 20 | 611 | |
Abbreviations: CI, confidence interval; ELISA, enzyme-linked immunosorbent assay.
Validity indicators of ELISA against microscopy
| Parameter | Estimate (95% CI) |
|---|---|
| Sensitivity | 90 |
| Specificity | 98.2 |
| PPV | 62.07 |
| NPV | 99.67 |
| Likelihood ratio positive test | 49.99 |
| Likelihood ratio negative test | 0.1018 |
| Diagnostic accuracy | 97.94 |
Abbreviations: CI, confidence interval; NPV, negative predictive value; PPV, positive predictive value.
Agreement between gold standard (microscopy) and PCR
| PCR | Microscopy | Kappa | |
|---|---|---|---|
| Positive | Negative | ||
|
| 20 | 10 | 0.72 (0.65–0.80) |
|
| 0 | 601 | |
|
| 20 | 611 | |
Abbreviations: CI, confidence interval; PCR, polymerase chain reaction.
Validity indicators of PCR against microscopy
| Parameter | Estimate (95% CI) |
|---|---|
| Sensitivity | 100 |
| Specificity | 98.36 |
| PPV | 66.67 |
| NPV | 100 |
| Likelihood ratio positive test | 61.1 |
| Likelihood ratio negative test | 0.0 |
| Diagnostic accuracy | 98.42 |
Abbreviations: CI, confidence interval; NPV, negative predictive value; PCR, polymerase chain reaction; PPV, positive predictive value.